Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Evofem Biosciences Q3 EPS $(0.01) Up From $(0.02) YoY, Sales $4.952M Up From $4.496M YoY

Author: Benzinga Newsdesk | November 13, 2025 06:14pm
Evofem Biosciences (OTC:EVFM) reported quarterly losses of $(0.01) per share. This is a 50 percent increase over losses of $(0.02) per share from the same period last year. The company reported $4.952 million in sales this quarter. This is a 10.14 percent increase over sales of $4.496 million the same period last year.

Posted In: EVFM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist